MYD88 and cancer: Furthermore the changes observed in MyD88 expression in embryonal carcinoma (EC) cancer stem cells, one of the best characterized CSC models in use today [30]–[32], also suggest that MyD88 positive cancer cells are more biologically aggressive than MyD88 negative cells.